Poonawalla Reaps Riches In Vaccine Rollouts
Cyrus Poonawalla has another passion besides horses and cars — making jabs for the masses.
serum institute of india
September 2023
April 2023
September 2022
April 2022
December 2021
Pharma's Richest Ride Demand Tailwinds
The stellar run continues post-Covid as promoters reap benefits of growth in India and new launches in key markets.
Serum Institute to double its investment in Biocon subsidiary to $300 mn
As per the new arrangement, Biocon Biologics will have access to 100 million doses of vaccines annually together with the distribution rights to Serum Institute’s vaccine portfolio.
Covid catapults Cyrus Poonawalla to richest in pharma
Cyrus Soli Poonawalla’s Serum Institute of India made the most of the country’s demand for vaccines.
Poonawalla, The Mass Saviour
The owner of world's biggest vaccine maker is also known for his interest in social causes.
Serum to launch India's first indigenous cervical cancer vaccine
While the initial rollout will be for supplies to the government vaccination programme, commercial open sales may begin early 2023, says Adar Poonawalla.
Serum not making fresh vaccines amid surplus stock: Poonawalla
Serum Institute chief executive Adar Poonawalla, during a media event today, said the company has 200 million doses of vaccine stock available currently.
Serum's Poonawalla pitches for global pandemic treaty for free flow of vaccines
India has learned a lot and is in a stronger and better position to face any future wave or future pandemics, says Adar Poonawalla.
Covid-19: 2 new vaccines, 1 drug join fight against virus in India
Covid-19 vaccines Corbevax and Covovax, and anti-viral medication Molnupiravir have been granted emergency use authorisation by the CDSCO.
Common global rules must for new Covid drug trials: Adar Poonawalla
Poonawalla says the biggest learning from the pandemic has been the realisation that one should not make forward looking predictions, as things have been changing fast with Covid-19
